Medbanks Set for IPO on Hong Kong Stock Exchange
Sipai Health Technology Co., Ltd, also known as Medbanks, is set to make an initial...
Sipai Health Technology Co., Ltd, also known as Medbanks, is set to make an initial...
Swiss giant Roche’s (SWX: ROG) China unit and Roche Diagnostics’ China unit entered into a...
Germany giant Merck (NYSE: MRK) struck a three-year partnership with Tsinghua Shenzhen International Graduate School,...
China-based Luye Pharma Group announced that it is handing Singapore distribution and marketing rights to...
Science Standard Medical Testing, a professional third-party testing institution based in Changzhou, reportedly raised “tens...
Sino-US biotech Phanes Therapeutics Inc. announced a clinical study cooperation and supply agreement with China-based...
Sino-US artificial intelligence (AI) firm XtalPi Inc. struck a partnership with China-based Jiangsu Chia Tai...
China-based Frontier Biotechnologies Inc. (SHA: 688221) announced a strategic collaboration agreement with compatriot firm Jiangsu...
Harbour BioMed (HKG: 2142), a biotech operating out of the Netherlands, the United States, and...
ExoNeuglia, a stem-cell-focused biotech based in Suzhou, reportedly raised “tens of millions” of renminbi in...
Yuanmai Cell Biotechnology Co., Ltd, a macrophage immunotherapy developer based in Nanjing, reportedly raised “tens...
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) announced the plan to acquire the...
Shanghai Hantong Medical Technology Co., Ltd reportedly raised “tens of millions” of renminbi in an...
China’s Suzhou GenAssist Therapeutics Co., Ltd, a base editing technology-based gene therapy developer, reportedly raised...
China-based Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864) announced a technology commission (development) agreement...
A new bar was set for the most valuable out-license deal struck by a China-based...
Beijing Qihui Biopharmaceuticals Co., Ltd reportedly raised “tens of millions” of renminbi in a Series...
Westgene Biopharma, an mRNA drug developer based in Chengdu, reportedly raised RMB 150 million (USD...
Shanghai-based Huihe Healthcare, an interventional medical device maker for heart diseases, reportedly raised “hundreds of...
China-based eye disease treatment technology company Chaomu Technology (Beijing) Co., Ltd reportedly raised close to...